Search

Your search keyword '"Giráldez Gallego Á"' showing total 39 results
Start Over Author "Giráldez Gallego Á"
39 results on '"Giráldez Gallego Á"'

1. Characterizing Hepatitis Delta in Spain and the gaps in its management

Author

Rodríguez-Tajes, Sergio, Palom, Adriana, Giráldez-Gallego, Álvaro, Moreno, Antonio, Urquijo, Juan José, Rodríguez, Manuel, Alvarez-Argüelles, Marta, Diago, Moisés, García-Eliz, María, Fuentes, Javier, Martínez-Sapiña, Ana María, Castillo, Pilar, Casado, Marta, Pérez-Campos, Elena, Muñoz, Raquel, Hernández-Conde, Marta, Morillas, Rosa María, Granados, Rafael, Miquel, Mireia, Morillas, María Julia, García-Retortillo, Monserrat, Carrión, Jose Antonio, Moreno, José María, Montón, Cristina, González-Santiago, Jesús Manuel, Lorente, Sara, Cabezas, Joaquín, Mateos, Beatriz, Vázquez-Rodríguez, Sergio, Díaz-Fontenla, Fernando, Pinazo, José María, Delgado, Mercè, Pérez-Palacios, Domingo, Horta, Diana, Fernández-Marcos, Cristina, López, Carmen, Calleja, José Luis, Fernández, Inmaculada, García-Samaniego, Javier, Forns, Xavier, Buti, María, and Lens, Sabela

Published
2024
Full Text
View/download PDF

2. Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry

Author

Andrade, RJ, Lucena, MI, Stephens, C, García-Cortés, M, Robles-Díaz, M, Medina-Cáliz, I, Sanabria, J, García-Muñoz, B, Alcántara, R, Moreno, I, Gonzalez-Jimenez, A, Ortega-Alonso, A, Sanjuán-Jiménez, R, Quirós, M, Martín-Reyes, F, Papineau, A, Jiménez-Pérez, M, González-Grande, R, Fernández, MC, Peláez, G, Casado, M, González-Sánchez, M, Romero-Gómez, M, Calle-Sanz, R, Millán-Domínguez, R, Fombuena, B, Gallego, R, Rojas, L, Rojas, A, Ampuero, J, del Campo, JA, Gil Gómez, A, Vilar, E, Castiella, A, Zapata, EM, Zubiaurre, L, Navarro, JM, Méndez-Sánchez, IM, Chaves, A, Soriano, G, Guarner, C, Román, EM, Hallal, H, García-Oltra, E, Titos-Arcos, JC, Pérez-Martínez, A, Sánchez-Cobarro, C, Egea-Caparrós, JM, Arenas, J, Gomez-Osua, MI, Gómez-García, A, Esandi, FJ, Blanco, S, Martínez-Odriozola, P, Otazua, P, Salmerón, J, Gila, A, Quiles, R, González, JM, Lorenzo, S, Prieto, M, Conde, I, Amiel, Berenguer, M, García-Eliz, M, Primo, J, Molés, JR, Garayoa, A, Carrascosa, M, Gómez- Domínguez, E, Montané, E, Arellano, AL, Barriocanal, AM, Sanz, Y, Morillas, RM, Sala, M, Masnou, H, Farré, M, Bruguera, M, Gines, P, Lens, S, García, JC, Aldea-Perona, A, Hernández-Guerra, M, Moreno-San Fiel, M, Boada-Fernández del Campo, C, Tejedor, M, González-Ferrer, R, Fernández, C, Fernández-Gil, M, Montero, JL, de la Mata, M, Fuentes-Olmo, J, Fernández-Bonilla, EM, González-Gallego, J, Jorquera, F, Moreno, JM, Martínez-Rodenas, P, Garrido, M, Rendón, P, Vergara, M, Sánchez Delgado, J, García Samaniego, J, Madejón, A, Cabriada, JL, Crespo, J, Giráldez Gallego, A, Cuaresma, M, Ruíz, R, Medina-Caliz, Inmaculada, Garcia-Cortes, Miren, Gonzalez-Jimenez, Andres, Cabello, Maria R., Robles-Diaz, Mercedes, Sanabria-Cabrera, Judith, Sanjuan-Jimenez, Rocio, Ortega-Alonso, Aida, García-Muñoz, Beatriz, Moreno, Inmaculada, Jimenez-Perez, Miguel, Fernandez, M Carmen, Ginés, Pere, Prieto, Martin, Conde, Isabel, Hallal, Hacibe, Soriano, German, Roman, Eva, Castiella, Agustin, Blanco-Reina, Encarnacion, Montes, Maria R., Quiros-Cano, Marta, Martin-Reyes, Flores, Lucena, M. Isabel, and Andrade, Raul J.

Published
2018
Full Text
View/download PDF

7. FRI-406 Real world outcomes of hepatitis delta patients with mild or moderate fibrosis

Author

Lens, Sabela, Kamal, Habiba, d'Almeida, Arno Furquim, Brichler, Segolene, Papatheodoridi, Margarita, Palom, Adriana, Casado-Martin, Marta, Bourgeois, Stefan, Diago, Moises, Lindahl, Karin, Conde, Marta Hernández, Rodríguez, Manuel, Moreno, Christophe, Giráldez-Gallego, Alvaro, Garcia-Samaniego, Francisco Javier, Sersté, Thomas, Cabezas, Joaquin, Delwaide, JeAn, Buti, Maria, Papatheodoridis, George, Roulot, Dominique, Vanwolleghem, Thomas, de Lédinghen, Victor, Aleman, Soo, and Panero, José Luis Calleja

Published
2024
Full Text
View/download PDF

9. WED-208 - Current status of hepatitis delta in Andalusia: multicenter study

Author

Casado, Marta, Castillo, Anny Camelo, Baena, Pilar Barrera, Perez Jimenez, Ana Belen, Bandera, Jose Pinazo, Viciana, Isabel, Aguilar, Juan Cristobal, Carlos, Juan, Arboledas, Alados, SantaMaria Rodriguez, German Jose, Freyre, Carolina, Villalba, Carmen Molina, Coronas, Joaquin Salas, Luzón-García, M. Pilar, Ruiz, Elena, Fernandez, Teresa Cabezas, del Pino, Pilar, De La Luna, Francisco Franco Álvarez, Cordero, Patricia, Arellano, Encarnación Ramirez, Giráldez-Gallego, Alvaro, Lozano Domínguez, María Carmen, Lopez Garrido, Maria Angeles, Sampedro, Antonio, González-Grande, Rocio, Palop, Begoña, Macías, Manuel, Montiel, Natalia, Molina, Laura Castillo, Roldan, Carolina, Fernández, Carmen Sendra, De La Iglesia Salgado, Alberto, Mate, Carlota Jimeno, del Carmen Domínguez, Maria, Fernández-Sánchez, Fernando, Rosales Zabal, Jose Miguel, and Garcia, Federico Garcia

Published
2023
Full Text
View/download PDF

10. WED-166 - Characterizing chronic hepatitis delta in Spain and the gaps in its management

Author

Rodriguez-Tajes, Sergio, Palom, Adriana, Giráldez-Gallego, Alvaro, Moreno, Antonio, Urquijo, Juan José, Celada-Sendino, Miriam, Diago, Moises, Eliz, María García, Olmo, Javier Fuentes, Castillo, Pilar, Casado, Marta, Martínez-Sapiña, Ana María, Campos, Elena Pérez, Gómez, Raquel Muñoz, Conde, Marta Hernández, Morillas, Rosa Maria, Granados, Rafael, Miquel, Mireia, Morillas, Julia, García-Retortillo, Montserrat, Carrión, Jose A., Moreno Planas, Jose María, Barciela, Mar Riveiro, Montón, Cristina, Santiago, Jesús González, Lorente, Sara, Llerena, Susana, Cabezas, Joaquín, Muñoz, Beatriz Mateos, Rodríguez, Sergio Vaquez, Diaz, Fernando, Bandera, Jose Pinazo, Gerra, Merce Delgado, Pérez-Palacios, Domingo, Horta, Diana, Marcos, Cristina Fernández, Núñez, Carmen López, Calleja Panero, José Luis, Vázquez, Inmaculada Fernández, Rodríguez, Manuel, Garcia-Samaniego Rey, Francisco Javier, Forns, Xavier, Buti, Maria, and Lens, Sabela

Published
2023
Full Text
View/download PDF

11. THU018 - Impact of sex and recurrence in the prognosis of alcoholic hepatitis

Author

Gratacós-Gines, Jordi, Rodríguez, Manuel, Giráldez-Gallego, Alvaro, Cabezas, Joaquín, Vázquez, Inmaculada Fernández, Cots, Meritxell Ventura, Horta, Diana, Sánchez-Delgado, Jordi, Acosta-López, Silvia, Varasa, Tomás Artaza, Marti-Aguado, David, Monterde, Vanesa Bernal, Martin-Mateos, Rosa, Clemente, Ana, Tejedor-Tejada, Javier, Bandera, Jose Pinazo, Sala, Margarita, Badia-Aranda, Esther, Sancho, Victoria Aguilera, Tomé, Santiago, Fernández-Rodríguez, Conrado, Caballería, Joan, and Pose, Elisa

Published
2022
Full Text
View/download PDF

13. SAT146 - Pre-emptive (early) transjugular intrahepatic porto-systemic shunt in the treatment of high-risk acute variceal bleeding. An individual patient data meta-analysis

Author

Garcia Pagan, Juan Carlos, Nicoara-Farcau, Oana, Angrisani, Debora, Monescillo, Alberto, Han, Guohong, Torres, Ferran, Bosch, Jaime, Casanovas, Georgina, Lv, Yong, Fan, Daiming, Bureau, Christophe, Nevens, Frederik, Caca, Karel, Luca, Angelo, Zipprich, Alexander, Procopet, Bogdan, Giraldez-Gallego, Alvaro, Amitrano, Lucio, Villanueva, Candid, Thabut, Dominique, Ibañez, Luis, Trebika, Jonel, Genesca, Joan, Palazon, Jose María, Alonso, José Castellote, Rodrigues, Susana G., Gluud, Lise Lotte, Ferlitsch, Prof. Dr. Arnulf, Noronha Ferreira, Carlos Alberto Costa, Mundi, Jose Luis, Grønbæk, Henning, Sassatelli, Romano, Dell’Era, Alessandra, Senzolo, Marco, Gomez, Manuel Romero, Guerra, Manuel Hernández, Casas, Meritxell, Primignani, Massimo, Krag, Aleksander, Calleja Panero, José Luis, Cañete, Nuria, Masnou, Helena, Mössner, Joachim, and Hernandez-Gea, Virginia

Published
2020
Full Text
View/download PDF

14. FRI278 - Persistently low platelet count and splenomegaly after treatment with oxaliplatin as markers of development of portal sinusoidal vascular disease

Author

Sanchez, Angela Puente, del Pozo, Carmen, Serrano, Marina, Giraldez-Gallego, Alvaro, Luis, Tellez, Martinez, Javier, Magaz, Marta, Ibañez, Luis, Garcia, Julia, Llop, Elba, Álvarez-Navascués, Carmen, Romero-Gutiérrez, Marta, Fortea, Jose Ignacio, Lopez, Carlos Lopez, Albillos, Agustin, Hernandez-Gea, Virginia, Garcia Pagan, Juan Carlos, Bañares, Rafael, and Crespo, Javier

Published
2020
Full Text
View/download PDF

15. AS103 - Early-tips should be performed in high-risk cirrhotic patients despite the presence of hepatic encephalopathy at admission

Author

Rudler, Marika, Hernandez-Gea, Virginia, Procopet, Bogdan, Giraldez-Gallego, Alvaro, Amitrano, Lucio, Villanueva, Candid, Ibañez, Luis, Silva-Junior, Gilberto, Martinez, Javier, Genesca, Joan, Bureau, Christophe, Jonel, Trebicka, Llop, Elba, Laleman, Wim, Palazon, Jose María, Alonso, José Castellote, Rodrigues, Susana G., Gluud, Lise Lotte, Ferreira, Carlos Noronha, Cañete, Nuria, Ferlitsch, Prof. Dr. Arnulf, Mundi, Jose Luis, Grønbæk, Henning, Hernandez-Guerra, Manuel, Sassatelli, Romanno, Dell’Era, Alessandra, Abraldes, Juan G., Barcelo, Rafael, Senzolo, Marco, Gomez, Manuel Romero, Zipprich, Alexander, Masnou, Helena, Primignani, Massimo, Krag, Aleksander, Torres, Ferran, Nevens, Frederik, Calleja Panero, José Luis, Casanovas, Georgina, Jansen, Christian, Albillos, Agustin, Maria, Guardascione, Alvarado, Edilmar, Casas, Meritxell, Robic, Marie-Angèle, Catalina, María-Vega, Sosa, Irene Conejo, Maxime, Mallet, Simona, Tripon, Bosch, Jaime, Garcia Pagan, Juan Carlos, and Thabut, Dominique

Published
2020
Full Text
View/download PDF

16. SAT-079-Respiratory infection in patients with cirrhosis and acute variceal bleeding on antibiotic prophylaxis: A multicenter observational study of 2138 patients

Author

Martinez, Javier, luis, Tellez, Hernandez-Gea, Virginia, Procopet, Bogdan, Giraldez-Gallego, Alvaro, Amitrano, Lucio, Villanueva, Candid, Thabut, Dominique, Ibañez, Luis, Silva-Junior, Gilberto, Genesca, Joan, christophe, Bureau, Llop, Elba, Laleman, Wim, Palazon, Jose María, Castellote, José, Rodrigues, Susana G., Gluud, Lise Lotte, Ferreira, Carlos Noronha, Barcelo, Rafael, Cañete, Nuria, Rodriguez, Manuel, Ferlitsch, Prof. Dr. Arnulf, Mundi, Jose Luis, Granbæk, Henning, Hernandez-Guerra, Manuel, Sassatelli, Romanno, Dell'Era, Alessandra, Senzolo, Marco, Abraldes, Juan, Romero-gómez, Manolo, Zipprich, Alexander, Casas, Meritxell, Masnou, Helena, Primignani, Massimo, Krag, Aleksander, Nevens, Frederik, Panero, José Luis Calleja, Jansen, Christian, Robic, Marie Angele, Conejo, Irene, Catalina, Maria-Vega, Rudler, Marika, Bañares, Rafael, Alvarado, Edilmar, Trebicka, Jonel, Guardascione, Maria Anna, Tantau, Marcel, Torres, Ferran, Bosch, Jaime, Carlos, Garcia Pagan Juan, and Albillos, Agustin

Published
2019
Full Text
View/download PDF

17. PS-023-Factors predicting survival in patients with high-risk acute variceal bleeding treated with pre-emptive (Early)-TIPS

Author

Angrisani, Debora, Hernandez-Gea, Virginia, Procopet, Bogdan, Caca, Karel, Giraldez-Gallego, Alvaro, Amitrano, Lucio, Guardascione, Maria Anna, Villanueva, Candid, Alvarado, Edilmar, Thabut, Dominique, Rudler, Marika, Ibañez, Luis, Bañares, Rafael, Catalina, María-Vega, Turon, Fanny, Albillos, Agustin, Martinez, Javier, Genesca, Joan, Sosa, Irene Conejo, Baiges, Anna, christophe, Bureau, Vinel, Jean Pierre, Robic, Marie-Angele, Sauerbruch, Tilman, TREBICKA, Jonel, Appenrodt, Beate, Jansen, Christian, Llop, Elba, Calleja Panero, José Luis, Laleman, Wim, Nevens, Frederik, Palazon, Jose María, Castellote, José, Rodrigues, Susana G., Gluud, Lise Lotte, Ferreira, Carlos Noronha, Cañete, Nuria, Tantau, Marcel, Magaz, Marta, Rodríguez, Manuel, Ferlitsch, Arnulf, Mundi, Jose Luis, Grønbæk, Henning, Hernandez-Guerra, Manuel, Ferrusquia, José, Mössner, Joachim, Sassatelli, Romanno, Dell'Era, Alessandra, Senzolo, Marco, ABRALDES, Juan G, Gomez, Manuel Romero, Zipprich, Alexander, Luca, Angelo, Casas, Meritxell, Masnou, Helena, Primignani, Massimo, Casanovas, Georgina, Torres, Ferran, Krag, Aleksander, Bosch, Jaime, Monescillo, Alberto, and GARCIA-PAGAN, Juan-Carlos

Published
2019
Full Text
View/download PDF

29. Recurrent alcohol-associated hepatitis is common and is associated with increased mortality.

Author

Gratacós-Ginès J, Ruz-Zafra P, Celada-Sendino M, Martí-Carretero A, Pujol C, Martín-Mateos R, Echavarría V, Frisancho LE, García S, Barreales M, Tejedor-Tejada J, Vázquez-Rodríguez S, Cañete N, Fernández-Carrillo C, Valenzuela M, Martí-Aguado D, Horta D, Quiñones M, Bernal-Monterde V, Acosta S, Artaza T, Pinazo J, Villar-Lucas C, Clemente-Sánchez A, Badia-Aranda E, Giráldez-Gallego Á, Rodríguez M, Sancho-Bru P, Cabezas J, Ventura-Cots M, Fernández-Rodríguez C, Aguilera V, Tomé S, Bataller R, Caballería J, and Pose E

Subjects
Humans, Male, Female, Middle Aged, Risk Factors, Adult, Spain epidemiology, Severity of Illness Index, Incidence, Prognosis, Aged, Hepatitis, Alcoholic mortality, Recurrence, Registries statistics & numerical data
Abstract

Background and Aims: Alcohol relapse after surviving an episode of alcohol-associated hepatitis (AH) is common. However, the clinical features, risk factors, and prognostic implications of recurrent alcohol-associated hepatitis (RAH) are not well described., Approach and Results: A registry-based study was done of patients admitted to 28 Spanish hospitals for an episode of AH between 2014 and 2021. Baseline demographics and laboratory variables were collected. Risk factors for RAH were investigated using Cox regression analysis. We analyzed the severity of the index episodes of AH and compared it to that of RAH. Long-term survival was assessed by Kaplan-Meier curves and log-rank tests. A total of 1118 patients were included in the analysis, 125 (11%) of whom developed RAH during follow-up (median: 17 [7-36] months). The incidence of RAH in patients resuming alcohol use was 22%. The median time to recurrence was 14 (8-29) months. Patients with RAH had more psychiatric comorbidities. Risk factors for developing RAH included age <50 years, alcohol use >10 U/d, and history of liver decompensation. RAH was clinically more severe compared to the first AH (higher MELD, more frequent ACLF, and HE). Moreover, alcohol abstinence during follow-up was less common after RAH (18% vs. 45%, p <0.001). Most importantly, long-term mortality was higher in patients who developed RAH (39% vs. 21%, p = 0.026), and presenting with RAH independently predicted high mortality (HR: 1.55 [1.11-2.18])., Conclusions: RAH is common and has a more aggressive clinical course, including increased mortality. Patients surviving an episode of AH should undergo intense alcohol use disorder therapy to prevent RAH., (Copyright © 2024 American Association for the Study of Liver Diseases.)

Published
2024
Full Text
View/download PDF

30. Investigating temporal patterns of colorectal cancer incidence in Spain: a comprehensive analysis of age, period and cohort effects, 1990-2019.

Author

Cayuela L, Flox-Benítez G, Peiró Villalba C, Giráldez Gallego Á, and Cayuela Domínguez A

Subjects
Humans, Spain epidemiology, Male, Female, Incidence, Middle Aged, Adult, Aged, Age Factors, Time Factors, Aged, 80 and over, Age Distribution, Sex Distribution, Cohort Studies, Colorectal Neoplasms epidemiology, Cohort Effect
Abstract

Aim: This study aimed to evaluate how age, period, and cohort (A-P-C) impact colorectal cancer (CRC) incidence in Spain from 1990 to 2019., Method: Using data from the Global Burden of Disease Study 2019, we used joinpoint analysis to identify long-term trends and A-P-C modelling to quantify net drift, local drift, longitudinal age curves, and rate ratios (RRs) of period and cohort effects., Results: CRC incidence increased steadily in Spain from 1990 to 2019, with a more significant rise in males than in females. The age standardized rates rose from 84.9 to 129.3 cases per 100,000 in males and from 56.9 to 70.3 cases per 100,000 in females. Joinpoint analysis revealed distinct patterns for men and women: male incidence showed three phases (a surge until 1995, a slowdown until 2012, and a subsequent decrease) while female incidence showed a single increase until 2011 and then stabilized. Local drifts increased in all age groups over 45, with stability in males under 45 and a decrease in females aged 30-39. The risk of CRC increased with age, with males consistently having a higher risk than females. The risk of CRC increased over time for both men and women but at different rates. The risk for cohorts born in the early to mid-20th century peaked in the 1960s and remained stable until the late 1990s., Conclusion: The increasing incidence of CRC in Spain, with distinct patterns by gender and birth cohort, underlines the importance of preventive strategies adapted to temporal and demographic variations to address this public health challenge.

Published
2024
Full Text
View/download PDF

31. Age, period and cohort effects on gastric cancer mortality in Spain, 1980-2021.

Author

Cayuela L, Giráldez Gallego Á, Garzón Benavides M, Sousa Martín JM, and Cayuela A

Subjects
Male, Female, Humans, Middle Aged, Young Adult, Adult, Spain epidemiology, Cohort Effect, Stomach Neoplasms epidemiology
Abstract

Background: this study aimed to evaluate the effects of age, time period and cohort (A-P-C) on gastric cancer (GC) mortality in Spain from 1980 to 2021., Methods: an ecological trend study was performed (with aggregated data obtained from the Spanish National Statistics Institute (INE). Joinpoint regression software was used to estimate rates by sex and age group (< 35, 35-64, > 64 years) and mortality trends. The National Cancer Institute A-P-C tools were used to assess the effects of age, time of death and birth cohort., Results: GC mortality rates in Spain decreased significantly in both sexes. In the under-35 age group, rates were stable after an initial significant decline. In the 35-64 age group, the decline was more pronounced in males than in females. In the 65+ age group, rates fell significantly for both sexes, but more so for females than for males. The net drift and local drift also showed significant decreases across all age groups from 24 years onwards. GC mortality rates increased with age and decreased with calendar time and successive birth cohorts, regardless of sex. The ratio of age-specific rates between males and females increased with age, and birth cohort relative risk estimates followed a steady downward trend until the mid-1970s, after which the decline stabilized. The relative risk decreased for both sexes, with a more pronounced decrease in males., Conclusion: GC mortality rates in Spain have been decreasing over time and across successive birth cohorts, with a stabilizing trend observed for those under 35 years of age.

Published
2024
Full Text
View/download PDF

32. Three double-dose reinforced hepatitis B revaccination scheme for patients with cirrhosis unresponsive to the standard regimen: an open-label randomised clinical trial.

Author

Giráldez-Gallego Á, Rodríguez-Seguel EDP, Valencia-Martín R, Morillo-García Á, Salamanca-Rivera C, Ruiz-Pérez R, Cuaresma-Duque M, Rosso-Fernández C, Ferrer-Ríos MT, Sousa-Martín JM, Praena-Fernández JM, Desongles-Corrales T, Rodríguez-Pérez A, Camino-Durán F, Gasch-Illescas A, Ampuero-Herrojo J, and Pascasio-Acevedo JM

Subjects
Child, Humans, Immunization, Secondary, Hepatitis B Antibodies, Severity of Illness Index, Liver Cirrhosis complications, Hepatitis B Vaccines, End Stage Liver Disease, Hepatitis B prevention & control
Abstract

Objective: We aimed to compare the response rates between two different hepatitis B virus vaccination schedules for cirrhotic subjects who were non-responders to the first three 40 µg doses (month 0-1-2), and identify factors associated with the final response., Design: A total of 120 cirrhotic patients (72.5% decompensated) were randomised at a 1:1 ratio to receive a single 40 µg booster vaccination at month 6 (classical arm) versus an additional round of three new 40 µg doses administered at monthly intervals (experimental arm). The main outcome was the rate of postvaccinal anti-hepatitis B surface antibodies levels ≥10 mIU/mL., Results: Efficacy by ITT analysis was higher in the experimental arm (46.7%) than in the classical one (25%); OR 2.63, p=0.013. The experimental arm increased response rates compared with the classical one from 31% to 68% (OR 4.72; p=0.007), from 24.4% to 50% (OR 3.09; p=0.012) and from 24.4% to 53.8% (OR 3.62; p=0.007), in Child A, Model for End-Stage Liver Disease (MELD) <15 and MELD-Na<15 patients, respectively. Patients with more advanced liver disease did not benefit from the reinforced scheme. Both regimens showed similar safety profiles. Multivariable analysis showed that the experimental treatment was independently response associated when adjusted across three logistic regression models indicating equivalent cirrhosis severity., Conclusion: For cirrhotic patients, the revaccination of non-responders to the first three dose cycle, with three additional 40 µg doses, achieved significantly better response rates to those obtained with an isolated 40 µg booster dose., Trial Registration Number: NCT01884415., Competing Interests: Competing interests: ÁG-G has received speaker fees from Gilead, Gore, MSD, BMS and Abbvie. MTF-R has received speaker fees from Bayer, Gilead, Abbvie and MSD. JMS-M has received lecture fees from Gilead, Abbvie and Intercept. JA has received speaker fees from Abbvie and Gilead, is an Advisory Board member of Intercept, GMP-Orphan and Novo Nordisk, and is supported by grants from Gilead. JMP-A has received lecture fees from Gilead, Abbvie and Astellas, and is supported by grants from Gilead. For all authors, both fees and grants were unrelated to the submitted work., (© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.)

Published
2023
Full Text
View/download PDF

34. Regenerative nodular hyperplasia, portal vein thrombosis and primary myelofibrosis: an unusual triple association.

Author

Sández Montagut VM, Giráldez Gallego Á, and Ontanilla Clavijo G

Subjects
Adult, Focal Nodular Hyperplasia diagnostic imaging, Focal Nodular Hyperplasia surgery, Humans, Male, Primary Myelofibrosis diagnostic imaging, Primary Myelofibrosis surgery, Thrombosis diagnostic imaging, Thrombosis surgery, Tomography, X-Ray Computed, Focal Nodular Hyperplasia complications, Portal Vein, Primary Myelofibrosis complications, Thrombosis complications
Abstract

We report a case of a regenerative nodular hyperplasia with a portal vein cavernomatosis with a subsequent progression to symptomatic, occlusive thrombosis of the superior mesenteric vein. A thorough investigation resulted in a final diagnosis of primary myelofibrosis associated with the V617F mutation in the JAK2 gene.

Published
2018
Full Text
View/download PDF

35. Hepatic veno-occlusive disease induced by Chinese medicinal herbs.

Author

Mejías Manzano MLÁ, Giráldez Gallego Á, and Serrano Jiménez M

Subjects
Hepatic Veno-Occlusive Disease pathology, Humans, Male, Middle Aged, Pyrrolizidine Alkaloids adverse effects, Drugs, Chinese Herbal adverse effects, Hepatic Veno-Occlusive Disease chemically induced
Abstract

The potential hepatotoxic effects of products containing medicinal herbs, which are increasingly used without adequate control by health authorities, is well known. We report a case of toxic hepatic veno-occlusive disease (HVOD) presumably associated with the use of such herbal remedies.

Published
2017
Full Text
View/download PDF

36. Canalicular cholestasis induced by anabolic steroids.

Author

Silva Ruiz MDP, Giráldez Gallego Á, and Serrano Jiménez M

Subjects
Biopsy, Cholestasis, Intrahepatic pathology, Humans, Male, Young Adult, Cholestasis, Intrahepatic chemically induced, Testosterone Congeners adverse effects
Abstract

Inappropriate use of anabolic steroids is increasing, usually by younger males in an illicit manner. This is a well-documented case of cholestatic hepatitis attributed to use of anabolic steroids for esthetic and/or athletic purposes.

Published
2017
Full Text
View/download PDF

37. Post-transfusion hyperhemolysis syndrome following gastrointestinal bleeding secondary to prehepatic portal hypertension.

Author

Mejías Manzano MLÁ, Giráldez Gallego Á, and Sánchez Torrijos YM

Subjects
Adrenal Cortex Hormones therapeutic use, Adult, Blood Transfusion, Female, Gastrointestinal Hemorrhage blood, Humans, Syndrome, Gastrointestinal Hemorrhage complications, Gastrointestinal Hemorrhage etiology, Hemolysis, Hypertension, Portal complications
Abstract

Supportive transfusion represents a basic tool in the management of gastrointestinal (GI) bleeding. However, the use of hemoderivatives is not exempt from risks such as development of hemolysis. We report a case of post-transfusion hyperhemolysis syndrome in a female patient with prehepatic portal hypertension.

Published
2017
Full Text
View/download PDF

38. Severe acute hepatitis and cold agglutinin-related hemolytic anemia secondary to prime infection with Epstein-Barr virus.

Author

Ontanilla Clavijo G, Praena Segovia J, Giráldez Gallego Á, Cordero Matía ME, and Sousa Martín JM

Subjects
Acute Disease, Adolescent, Anemia, Hemolytic, Autoimmune diagnosis, Epstein-Barr Virus Infections complications, Epstein-Barr Virus Infections immunology, Female, Hepatitis, Viral, Human complications, Hepatitis, Viral, Human immunology, Humans, Infectious Mononucleosis complications, Infectious Mononucleosis diagnosis, Infectious Mononucleosis immunology, Severity of Illness Index, Anemia, Hemolytic, Autoimmune virology, Epstein-Barr Virus Infections diagnosis, Hepatitis, Viral, Human diagnosis
Abstract

Epstein-Barr virus, a member of the Herpesviridae family, is responsible for the infectious mononucleosis clinical syndrome, which mainly includes the pharyngitis, fever, and lymphadenopathy triad after incubation for 30-50 days. The liver is involved in 80-90% of patients in a self-limiting transient manner, with jaundice being much more uncommon (5%). From a hematological standpoint it may manifest aplastic anemia, neutropenia, and thrombocytopenia. We report a case of infectious mononucleosis that included severe acute hepatitis and was associated with severe hemolytic anemia secondary to cold agglutinins. After exclusion of other etiologies, and given the clinical suspicion of the above association, which was later confirmed by lab tests, empiric therapy was initiated with antiviral agents (aciclovir + valganciclovir) and corticoids, which resulted in a progressive clinical improvement until complete remission. Therefore, we believe that this case report will reinforce the clinical evidence in support of the above combined therapy for serious infectious mononucleosis as a step prior to liver transplantation.

Published
2017
Full Text
View/download PDF

39. Portal vein thrombosis following endoscopic treatment for gastric varices with N-butyl-2-cyanoacrylate: Management with TIPS.

Author

Márquez-Galisteo C, Giráldez-Gallego Á, Nacarino-Mejías V, Rincón-Gatica A, and López-Ruiz T

Subjects
Aged, Enbucrilate therapeutic use, Female, Hemostasis, Endoscopic methods, Humans, Portasystemic Shunt, Transjugular Intrahepatic, Sclerosing Solutions therapeutic use, Venous Thrombosis therapy, Enbucrilate adverse effects, Esophageal and Gastric Varices therapy, Gastrointestinal Hemorrhage therapy, Hemostasis, Endoscopic adverse effects, Portal Vein, Sclerosing Solutions adverse effects, Venous Thrombosis etiology
Published
2015

Catalog

Books, media, physical & digital resources
See catalog results